125 related articles for article (PubMed ID: 9865512)
41. Nitric oxide synthase inhibition increases vascular resistance in sodium and water loaded rats.
Hably C; Vág J; Bartha J
Res Exp Med (Berl); 1998 Oct; 198(3):145-56. PubMed ID: 9820901
[TBL] [Abstract][Full Text] [Related]
42. Proteinuria is reduced by inhibition of inducible nitric oxide synthase in rat renal ischemia-reperfusion injury.
Kadkhodaee M; Zahmatkesh M; Sadeghipour HR; Eslamifar A; Taeb J; Shams A; Mahdavi-Mazdeh M
Transplant Proc; 2009 Sep; 41(7):2907-9. PubMed ID: 19765470
[TBL] [Abstract][Full Text] [Related]
43. Comparative haemodynamic studies of resting and active skeletal muscle in anaesthetised rats: role of nitric oxide.
Hably C; Vág J; Bartha J
Acta Physiol Hung; 2001; 88(1):25-33. PubMed ID: 11811844
[TBL] [Abstract][Full Text] [Related]
44. Interactions between inducible nitric oxide synthase and heme oxygenase-1 in glomerulonephritis.
Datta PK; Gross EJ; Lianos EA
Kidney Int; 2002 Mar; 61(3):847-50. PubMed ID: 11849436
[TBL] [Abstract][Full Text] [Related]
45. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
Suliburk JW; Helmer KS; Kennison SD; Mercer DW; Robinson EK
J Surg Res; 2005 Dec; 129(2):265-71. PubMed ID: 16026802
[TBL] [Abstract][Full Text] [Related]
46. Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia.
Cheng X; Leung SW; Lo LS; Pang CC
Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):372-9. PubMed ID: 12690429
[TBL] [Abstract][Full Text] [Related]
47. Induced nitric oxide promotes intestinal inflammation following hemorrhagic shock.
Hierholzer C; Kalff JC; Billiar TR; Bauer AJ; Tweardy DJ; Harbrecht BG
Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G225-33. PubMed ID: 14715517
[TBL] [Abstract][Full Text] [Related]
48. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia.
Matejovic M; Krouzecky A; Martinkova V; Rokyta R; Kralova H; Treska V; Radermacher P; Novak I
Shock; 2004 May; 21(5):458-65. PubMed ID: 15087823
[TBL] [Abstract][Full Text] [Related]
49. Effect of L-N6-(1-iminoethyl)-lysine, an inducible nitric oxide synthase inhibitor, on murine immune response induced by Actinobacillus actinomycetemcomitans lipopolysaccharide.
Sosroseno W; Musa M; Ravichandran M; Fikri Ibrahim M; Bird PS; Seymour GJ
J Periodontal Res; 2007 Apr; 42(2):124-30. PubMed ID: 17305870
[TBL] [Abstract][Full Text] [Related]
50. Inducible nitric oxide synthase attenuates chronic colitis in human histocompatibility antigen HLA-B27/human beta2 microglobulin transgenic rats.
Blanchard HS; Dernis-Labous E; Lamarque D; Nhieu JT; Szepes Z; Fléjou JF; Wollman E; Whittle BJ; Breban M
Eur Cytokine Netw; 2001 Mar; 12(1):111-8. PubMed ID: 11282554
[TBL] [Abstract][Full Text] [Related]
51. L-N6-(1-iminoethyl)-lysine (L-NIL) but not S-methylisothiourea sulphate (SMT) displays selectivity towards NOS-2.
Chłopicki S; Olszanecki R; Jakubowski A; Lomnicka M; Gryglewski RJ
Pol J Pharmacol; 1999; 51(5):443-7. PubMed ID: 10817546
[TBL] [Abstract][Full Text] [Related]
52. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
Guo L; Tabrizchi R
Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
[TBL] [Abstract][Full Text] [Related]
53. Ethanol inhibits lung clearance of Pseudomonas aeruginosa by a neutrophil and nitric oxide-dependent mechanism, in vivo.
Greenberg SS; Zhao X; Hua L; Wang JF; Nelson S; Ouyang J
Alcohol Clin Exp Res; 1999 Apr; 23(4):735-44. PubMed ID: 10235311
[TBL] [Abstract][Full Text] [Related]
54. Effect of chronic treatment with the inducible nitric oxide synthase inhibitor N-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits.
Behr-Roussel D; Rupin A; Simonet S; Bonhomme E; Coumailleau S; Cordi A; Serkiz B; Fabiani JN; Verbeuren TJ
Circulation; 2000 Aug; 102(9):1033-8. PubMed ID: 10961969
[TBL] [Abstract][Full Text] [Related]
55. 5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors.
Hallinan EA; Hagen TJ; Bergmanis A; Moore WM; Jerome GM; Spangler DP; Stevens AM; Shieh HS; Manning PT; Pitzele BS
J Med Chem; 2004 Feb; 47(4):900-6. PubMed ID: 14761191
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis.
Gabbai FB; Boggiano C; Peter T; Khang S; Archer C; Gold DP; Kelly CJ
J Immunol; 1997 Dec; 159(12):6266-75. PubMed ID: 9550431
[TBL] [Abstract][Full Text] [Related]
57. Selective inhibition of inducible nitric oxide synthase attenuates renal ischemia and damage in experimental heatstroke.
Lee CC; Lee YY; Chang CK; Lin MT
J Pharmacol Sci; 2005 Sep; 99(1):68-76. PubMed ID: 16127242
[TBL] [Abstract][Full Text] [Related]
58. Effects of a nitric oxide synthase inhibitor in humans with septic shock.
Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P
Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor.
Hallinan EA; Tsymbalov S; Dorn CR; Pitzele BS; Hansen DW; Moore WM; Jerome GM; Connor JR; Branson LF; Widomski DL; Zhang Y; Currie MG; Manning PT
J Med Chem; 2002 Apr; 45(8):1686-9. PubMed ID: 11931623
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
